Skip to main content

Day: January 29, 2025

Sound Financial Bancorp, Inc. Q4 2024 Results

SEATTLE, Jan. 29, 2025 (GLOBE NEWSWIRE) —  Sound Financial Bancorp, Inc. (the “Company”) (Nasdaq: SFBC), the holding company for Sound Community Bank (the “Bank”), today reported net income of $1.9 million for the quarter ended December 31, 2024, or $0.74 diluted earnings per share, as compared to net income of $1.2 million, or $0.45 diluted earnings per share, for the quarter ended September 30, 2024, and $1.2 million, or $0.47 diluted earnings per share, for the quarter ended December 31, 2023. The Company also announced today that its Board of Directors declared a cash dividend on the Company’s common stock of $0.19 per share, payable on February 26, 2025 to stockholders of record as of the close of business on February 12, 2025.Comments from the President and Chief Executive Officer   “The...

Continue reading

Methanex Reports Higher Production and Adjusted EBITDA in Fourth Quarter 2024

Except where otherwise noted, all currency amounts are stated in United States dollars. Financial and Production HighlightsNet income attributable to Methanex shareholders of $45 million and Adjusted EBITDA of $224 million in the fourth quarter. Our average realized price in the fourth quarter was $370 per tonne compared to $356 per tonne in the third quarter of 2024.Full year 2024 net income attributable to Methanex shareholders of $164 million and Adjusted EBITDA of $764 million.Fourth quarter production of 1,868 kmt was higher than third quarter production of 1,347 kmt driven by higher production from Chile, New Zealand, Geismar, and Egypt.In 2024, $50 million was returned to shareholders through regular dividends and the $300 million bond due in December was repaid with cash flows generated from operations. We ended the year...

Continue reading

Enovix to Release Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025

FREMONT, Calif., Jan. 29, 2025 (GLOBE NEWSWIRE) — Enovix Corporation (“Enovix”) (Nasdaq: ENVX), a global high-performance battery company, today announced it will release financial results for the fourth quarter and full year 2024 on Wednesday, February 19, 2025, after the close of the market. Enovix will hold a live video call at 2:00 PM PT / 5:00 PM ET on February 19, 2025, to discuss the company’s business updates, key milestones, and financial results. To join the call, participants must use the following link to register: https://enovix-q4-2024.open-exchange.net/. This link will also be available via the Investor Relations section of Enovix’s website at https://ir.enovix.com. Investors may also submit questions on the registration page that they would like addressed on the call by Enovix management. An archived version of...

Continue reading

North American Construction Group Ltd. Announces Early Redemption of 5.5% Debentures Due June 30, 2028

ACHESON, Alberta, Jan. 29, 2025 (GLOBE NEWSWIRE) — North American Construction Group Ltd. (“NACG” or “the Company”) (TSX:NOA/NYSE:NOA) announced today that it has delivered notice to the holders of the Company’s outstanding 5.5% convertible unsecured subordinated debentures due June 30, 2028 (the “Debentures”) that pursuant to Section 4.3 of the trust indenture governing the Debentures dated June 1, 2021 (the “Trust Indenture”), the Company will, effective February 28, 2025 (the “Redemption Date”), redeem all issued and outstanding Debentures, plus accrued interest thereon. In accordance with the Trust Indenture, holders of these Debentures may convert the outstanding Debentures into common shares of the Company at a price of $24.23 per share, which is at a discount to the closing price of NACG’s common shares of $28.45 per share...

Continue reading

Silexion Therapeutics Announces Exercise of Warrants for $3.3 Million Gross Proceeds

Cayman Islands, January 29, 2025 — Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion Therapeutics” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven cancers, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 2,221,523 of the Company’s ordinary shares originally issued in January 2025 having an exercise price of $1.35 per share. The ordinary shares issuable upon exercise of the warrants are registered pursuant to an effective registration statement on Form S-1 (No. 333-282932). The gross proceeds to the Company from the exercise of the warrants are expected to be approximately $3.3 million, prior to deducting placement agent fees and estimated offering expenses. The offering is...

Continue reading

MEDIROM Healthcare Technologies Inc. Announces December 2024 Key Performance Indicators (KPIs)

Total Customers Served: 80,764 – Sales Per Customer: JPY 7,384 – Customer Repeat Ratio: 77.6% TOKYO, Jan. 29, 2025 (GLOBE NEWSWIRE) — MEDIROM Healthcare Technologies Inc. (NasdaqCM: MRM), a holistic healthcare company based in Japan (the “Company”), today announced its major Key Performance Indicators, or KPIs, updated for the month of December 2024. Data is provided for all salons for which comparable financial and customer data is available and excludes certain salons where such information is not available. Salon Operation BusinessThe following monthly KPIs provide insight into the business fundamentals and progress of the Company, updated for the month of December 2024:Sales per customer increased to JPY 7,384 in December 2024 from JPY 7,271 in the year-ago period.  Number of Salons(*1) Number of Salons with Data(*2) Total...

Continue reading

Sanofi: Information concerning the total number of voting rights and shares – December 2024

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority) Sanofia French société anonyme with a registered share capital of 2,526,245,442 €Registered office : 46, avenue de la Grande Armée – 75017 Paris – FranceRegistered at the Paris Commercial and Companies Registry under number 395 030 844DateTotal number of issued sharesNumber of real voting rights(excluding treasury shares) Theoretical number of voting rights (including treasury shares)*December 31, 2024 1,263,122,721 1,413,130,110 1,422,661,191* Pursuant to article 223-11 of the Règlement général de l’Autorité des Marchés Financiers. This...

Continue reading

Plum Acquisition Corp. IV Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on January 31, 2025

NEW YORK, NY, Jan. 29, 2025 (GLOBE NEWSWIRE) — Plum Acquisition Corp. IV. (Nasdaq: PLMKU) (the “Company”) today announced that, commencing on January 31, 2025, holders of the units (the “Units”) sold in the Company’s initial public offering may elect to separately trade the Company’s Class A ordinary shares (the “Ordinary Shares”) and warrants (the “Warrants”) included in the Units. The Ordinary Shares and Warrants received from the separated Units will trade on the Nasdaq Global Market (“Nasdaq”) under the symbols “PLMK” and “PLMKW”, respectively. Units that are not separated will continue to trade on Nasdaq under the symbol “PLMKU”. No fractional Warrants will be issued upon separation of the Units and only whole Warrants will trade. Holders of Units will need to have their brokers contact Continental Stock Transfer & Trust...

Continue reading

Exco Technologies Limited Announces Results for First Quarter Ended December 31, 2024

Consolidated Sales of $146.6 million compared to $156.7 million the prior year Net Income of $4.2 million EPS of $0.11 compared to $0.15 last year EBITDA of $16.7 million compared to $18.1 million the prior year quarter Quarterly dividend of $0.105 per common share to be paid March 31, 2025TORONTO, Jan. 29, 2025 (GLOBE NEWSWIRE) — Exco Technologies Limited (TSX-XTC) today announced results for its first quarter ended December 31, 2024. In addition, Exco announced a quarterly dividend of $0.105 per common share which will be paid on March 31, 2025 to shareholders of record on March 17, 2025. The dividend is an “eligible dividend” in accordance with the Income Tax Act of Canada.  Three Months EndedDecember 31(in $ thousands except per share amounts)     2024    2023  Sales $143,568   $156,710  Net income for the...

Continue reading

HII Begins Fabrication of Amphibious Transport Dock Philadelphia (LPD 32)

PASCAGOULA, Miss., Jan. 29, 2025 (GLOBE NEWSWIRE) — HII (NYSE: HII) Ingalls Shipbuilding division began fabrication of the U.S. Navy’s newest San Antonio-class amphibious transport dock Philadelphia (LPD 32) Monday. The start of fabrication signifies that the first 100 tons of steel have been cut for the ship. “From the earliest planning stages to the first cut of steel, every step of construction so far has been focused on building a capable ship for our Navy and Marine Corps partners,” said Stephen Janowski, Ingalls Shipbuilding amphibious ship program manager. “Our team is committed to continuous improvement and seeing Philadelphia built with the quality craftsmanship needed to support our nation well into the future.” Ingalls is the sole provider of LPD 17 San Antonio-class ships and has delivered LPDs 17 through 29 to date....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.